![Jakob Brix Christensen](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jakob Brix Christensen
Directeur Général chez
Unibio AS
Profil
Jakob Brix Christensen is currently the Co-Chief Executive Officer at Unibio.
AS since 2021.
Prior to this, he worked as the Director-Investor Relations at Origio A from 2007 to 2012, Senior Manager-Business Finance at Novozymes A from 2012 to 2013, Partner-Business Finance at Albumedix A from 2013 to 2015, and Chief Financial Officer at Bioporto A from 2016 to 2018.
Postes actifs de Jakob Brix Christensen
| Sociétés | Poste | Début |
|---|---|---|
Unibio AS
 Unibio AS BiotechnologyHealth Technology Operates as a biotechnology company | Directeur Général | 27/06/2021 |
Anciens postes connus de Jakob Brix Christensen
| Sociétés | Poste | Fin |
|---|---|---|
| BIOPORTO A/S | Directeur Financier/CFO | 01/06/2018 |
Albumedix A/S
 Albumedix A/S Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company | Corporate Officer/Principal | 01/12/2015 |
Novozymes A/S
 Novozymes A/S Chemicals: SpecialtyProcess Industries Manufactures and sells specialty chemicals | Corporate Officer/Principal | 01/04/2013 |
Origio A/S
 Origio A/S BiotechnologyHealth Technology Manufactures and markets assisted reproduction technologies and related human reproductive products | Public Communications Contact | 01/04/2012 |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
19
Relations au 1er degré
5
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
Novozymes A/S
Novozymes A/S Chemicals: SpecialtyProcess Industries Manufactures and sells specialty chemicals | Process Industries |
Bioporto A/S
 Bioporto A/S Medical SpecialtiesHealth Technology Develops and markets human and animal neutrophil gelatinase-associated lipocalin antibodies kits | Health Technology |
Origio A/S
Origio A/S BiotechnologyHealth Technology Manufactures and markets assisted reproduction technologies and related human reproductive products | Health Technology |
Albumedix A/S
Albumedix A/S Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company | Health Technology |
Unibio AS
Unibio AS BiotechnologyHealth Technology Operates as a biotechnology company | Health Technology |
